- Home
- Labeler Index
- Patheon Biologics Llc
- 67920-1002
- NDC Crossover: 67920-1002 Ravulizumab
NDC Crossover 67920-1002 Ravulizumab
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Ravulizumab
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 67920-1002 – Ravulizumab, drug for further processing. This list includes other cross-matching products that share:
- The same product name: Ravulizumab
- OR Generic name: Ravulizumab
- AND the same Administration Route:
- OR Dosage Form: solution, concentrate
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 25682-022 | Ultomiris | Ravulizumab | Solution, Concentrate | Intravenous | Alexion Pharmaceuticals Inc. | Human Prescription Drug |
| 25682-025 | Ultomiris | Ravulizumab | Solution, Concentrate | Intravenous | Alexion Pharmaceuticals Inc. | Human Prescription Drug |
| 25682-028 | Ultomiris | Ravulizumab | Solution, Concentrate | Intravenous | Alexion Pharmaceuticals Inc. | Human Prescription Drug |